Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

634 ARTÍCULOS , VIENDO DEL 571 AL 585

Patient Preferences for Dementia Interventions: A Scoping Review With a Systematic Review of Medications and Choice-Based Methods

Gupta R, Lin S, DiStefano MJ, Woo HYJ, Mao E, Wilson R, Amjad H, Drabo EF, Segal JB.

J Am Geriatr Soc. 2026 Mar;74(3):868-882. doi: 10.1111/jgs.70209. Epub 2025 Nov 26.

Design strategies, structural insights, and biological potential of amyloid-beta inhibitors in Alzheimer's disease

Guleria M, Malhan A, Teli G, Bisht N, Jain SK.

Mol Divers. 2026 Feb;30(1):273-298. doi: 10.1007/s11030-025-11278-4. Epub 2025 Jul 3.

A Narrative Review on the Neuroprotective Effects of Selenium and Vitamin D in Alzheimer's Disease

Bragais EK, Luna KLD, Timoteo-Garcia VJ.

Biol Trace Elem Res. 2026 Mar;204(3):1848-1865. doi: 10.1007/s12011-025-04788-7. Epub 2025 Aug 14.

Alzheimer's disease prevention by flavonols and their analogs

Uhl G, Kannan B, Choi J, Henderson I.

J Prev Alzheimers Dis. 2026 Jan;13(1):100361. doi: 10.1016/j.tjpad.2025.100361. Epub 2025 Sep 3.

Nanotechnology-driven approaches for the early detection and targeted treatment of Alzheimer's disease

Sharma DK.

J Drug Target. 2026 Mar;34(3):372-389. doi: 10.1080/1061186X.2025.2561788. Epub 2025 Sep 19.

Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management

Singh B, Mahajan S, Abdella S, Khan R, Garg S.

Med Res Rev. 2026 Jan;46(1):272-298. doi: 10.1002/med.70013. Epub 2025 Sep 29.

The therapeutic efficacy of nanoparticles in the treatment of alzheimer's disease

Ntondini TL, Naki T, Alven S.

Acta Neurol Belg. 2026 Feb;126(1):35-53. doi: 10.1007/s13760-025-02905-w. Epub 2025 Oct 13.

Pharmacological Regulation of Mitophagy by Natural Plant Products as a Therapeutic Target for Alzheimer's Disease

Shao S, Lu H, Zu R, Chen Y, Peng Z, Peng Q, Ma H, Sun Y.

Phytother Res. 2026 Jan;40(1):248-266. doi: 10.1002/ptr.70131. Epub 2025 Nov 21.

Insulin resistance as a mediator of physical activity's effects on beta-amyloid accumulation and tau phosphorylation: A scoping review

Slee MG, Scotney J, Rainey-Smith SR, Erickson KI, Sohrabi HR, Verdile G, Brown BM.

Ageing Res Rev. 2026 Jan;114:102956. doi: 10.1016/j.arr.2025.102956. Epub 2025 Nov 24.

Pharmacological modulation of the PI3K/AKT/GSK3β axis: a new frontier in Alzheimer's disease treatment

Alqahtani SM, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Shokr MM, Alexiou A, Papadakis M, Batiha GE.

Inflammopharmacology. 2026 Jan;34(1):267-283. doi: 10.1007/s10787-025-02000-9. Epub 2025 Nov 26.

Sirtuins in Alzheimer's disease: mechanistic insights and therapeutic opportunities

Bai N, Liu S, Wei J, Zheng B, Wang W, Li X, Yang J, Song X, Wang L, Yi F, Cao L.

Trends Pharmacol Sci. 2026 Jan;47(1):100-119. doi: 10.1016/j.tips.2025.10.016. Epub 2025 Nov 26.

Targeting protein kinase C signaling cascades in alzheimer's disease: emerging neuroprotective roles of aurothioglucose

Kushawaha SK, Vashisht K, Kumar H, Ashawat MS, Baldi A.

Inflammopharmacology. 2026 Jan;34(1):243-254. doi: 10.1007/s10787-025-02077-2. Epub 2025 Dec 3.

Neuroprotective potential of Rhus coriaria: Insights into acetylcholinesterase inhibition and amyloid-β modulation

Ahmed A, Khan H, Shen Y, Xu S, Zhao Y, Lv J, Zhu X, Fu X, Li P.

J Alzheimers Dis. 2026 Feb;109(3):1053-1067. doi: 10.1177/13872877251404020. Epub 2025 Dec 15.

Therapeutics immunotargets for Tauopathy

Chinnathambi S, Rangappa N.

Adv Protein Chem Struct Biol. 2026;151:267-302. doi: 10.1016/bs.apcsb.2025.10.015. Epub 2025 Nov 4.

A Change of Mind: Targeting Amyloid-β with Better Safety Profile

Krick KE, Wilcock DM.

Annu Rev Pharmacol Toxicol. 2026 Jan;66(1):391-403. doi: 10.1146/annurev-pharmtox-062124-113434. Epub 2025 Jun 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias